Atlas Trials

A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132

Clinical trial NCT04755985 · COMPLETED

Trial details

NCT number
NCT04755985
Sponsor
Addpharma Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastroesophagus Reflux Disease
Start date
2021-03-21
Primary completion
2021-05-13
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.